Advanced search
Publication Cover
Pharmacogenomics Volume 7, 2006 - Issue 5
Submit an article Journal homepage
497
Views
2
CrossRef citations to date
0
Altmetric
Research Report

IL-1B and IL-1RN Gene Polymorphisms in Rheumatoid Arthritis: Relationship with Protein Plasma Levels and Response to Therapy

Barbara Tolusso1 UCSC – Catholic University of Rome, Division of Rheumatology, 00168Rome, Italy. Tel: +39 06 350 3654; Fax: +39 06 350 3523;[email protected]View further author information
,
Donatello Pietrapertosa1 UCSC – Catholic University of Rome, Division of Rheumatology, 00168Rome, Italy. Tel: +39 06 350 3654; Fax: +39 06 350 3523;[email protected]View further author information
,
Alessia Morelli1 UCSC – Catholic University of Rome, Division of Rheumatology, 00168Rome, Italy. Tel: +39 06 350 3654; Fax: +39 06 350 3523;[email protected]View further author information
,
Maria De Santis1 UCSC – Catholic University of Rome, Division of Rheumatology, 00168Rome, Italy. Tel: +39 06 350 3654; Fax: +39 06 350 3523;[email protected]View further author information
,
Elisa Gremese1 UCSC – Catholic University of Rome, Division of Rheumatology, 00168Rome, Italy. Tel: +39 06 350 3654; Fax: +39 06 350 3523;[email protected]View further author information
,
Giuseppina Farina1 UCSC – Catholic University of Rome, Division of Rheumatology, 00168Rome, Italy. Tel: +39 06 350 3654; Fax: +39 06 350 3523;[email protected]View further author information
,
Siro Giorgio Carniello2 Hospital of Sacile, Division of Medicine, Pordenone, ItalyView further author information
,
Marino Del Frate3 Hospital of Gorizia, Division of Medicine, ItalyView further author information
&
Gianfranco Ferraccioli1 UCSC – Catholic University of Rome, Division of Rheumatology, 00168Rome, Italy. Tel: +39 06 350 3654; Fax: +39 06 350 3523;[email protected]View further author information
 show all
Pages 683-695 | Published online: 03 Aug 2006

Bibliography

  • Wordsworth BP , StedefordJ, Rosenberg WM, Bell JI: Limited heterogeneity of the HLA class II contribution to susceptibility to rheumatoid arthritis is suggested by positive association with HLA-DR4, DR1 and DRw10. Br. J. Rheumatol.30, 176–180 (1991).
  • MacKay K , EyreS, MyerscoughA: Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom.Arthritis Rheum.46, 632–639 (2002).
  • Barrera P , FaureS, PrudhommeJ et al.: European genetic study on rheumatoid arthritis: is there a linkage of the interleukin-1 (IL-1), IL-10 or IL-4 genes to RA? Clin. Exp. Rheumatol.19, 709–714 (2001).
  • Genevay S , Di Giovine F, Perneger T: Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthritis Rheum.47, 303–309 (2002).
  • Lard LR , BoersM, VerhoevenA et al.: Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. Arthritis Rheum.46, 899–905 (2002).
  • Padyukov L , LampaJ, HeimbürgerM et al.: Genetic marker for the efficacy of tumor necrosis factor blocking therapy in rheumatoid arthritis. Ann. Rheum. Dis.62, 526–529 (2003).
  • Mugnier B , BalandraudN, DarqueA, RoudierC, RoudierJ, RevironD: Polymorphism at position -308 of the tumor necrosis factor α gene influences outcome of infliximab therapy in rheumatoid arthritis.Arthritis Rheum.48, 1849–1852 (2003).
  • Cuchacovich M , FerreiraL, AlisteM et al.: Tumor necrosis factor-α (TNF- α) levels and influence of -308 TNF- α promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis. Scand. J. Rheumatol.33, 228–232 (2004).
  • Fabris M , TolussoB, Di Poi E, Assaloni R, Sinigaglia L, Ferraccioli GF: Tumor necrosis factor receptor II polymorphism in patients from southern Europe with mild–moderate and severe rheumatoid arthritis. J. Rheum.29, 1847–1850 (2002).
  • Dinarello CA : The biological properties of interleukin-1.Eur. Cytokine Netw.5, 517–531 (1994).
  • Nicklin MJ , WeithA, DuggGW: A physical map of the region encompassing the human interleukin-1-β, interleukin-1-β and interleukin-1 receptor antagonist genes.Genomics19, 382–384 (1994).
  • Di G iovine FS, Takhsh E, Blakemore AI, Duff GW: Single base polymorphism at -511 in the human interleukin-1β gene. Hum. Mol. Genet.1, 450–451 (1992).
  • Pociot F , MolvigJ, WogensenL, WorsaaeH, NerupJ: A TaqI polymorphism in the human interleukin-1 β (IL-1 β) gene correlates with IL-1 β secretion in vitro.Eur. J. Clin. Invest.22, 396–402 (1992).
  • Tarlow JK , BlakemoreAI, LennardA et al.: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet91, 403–404 (1993).
  • Hulkkonen J , Laippala P, Hurme M: A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 β plasma levels in healthy individuals. Eur. Cytokine Netw.11, 251–255 (2000).
  • Kaijzel: EL , van Dongen H, Bakker AM, Breedveld FC, Huizinga TW, Verweij CL: Relationship of polymorphisms of the interleukin-1 gene cluster to occurance and severity of rheumatoid arthritis. Tissue Antigens59, 122–126 (2002).
  • Tarlow JK , CorkMJ, ClayFE et al.: Association between inteleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis. Br. J. Dermatol.136, 147–148 (1997).
  • van der Paardt M , CrusiusJB, Garcia-GonzalesMA et al.: Interleukin-1β and interleukin-1 receptor antagonist gene polymorphism in ankylosing spondylitis. Rheumatology41, 1419–1423 (2002).
  • Mansfield JC , HoldenH, TarlowJK et al.: Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology106, 637–642 (1994).
  • Arnett FC , EdworthySM, BlochDA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum.31, 315–324 (1988).
  • van Gestel AM , PrevooML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL: Development and validation of the European League Against Rheumatism response criteria in rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization (International League Agaisnt Rheumatism). Arthritis Rheum.39, 34–40 (1996).
  • Miller SA , DykesDD, PoleskyHF: A simple salting out procedure for extracting DNA from human nucleated cells.Nucleic Acid Res.16, 1215 (1988).
  • Kanemoto K , KawasakiJ, MiyamotoT, ObayashiH, NishimuraM: Interleukin (IL)-1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy.Ann. Neurol.47, 571–574 (2000).
  • Hurme M , SantillaS: IL-1 receptor antagonist (IL-1 R α) plasma levels are co-ordinately regulated by both IL1-R α and IL-1β genes.Eur. J. Immunol.28, 2598–2602 (1998).
  • Stephens M , SmithNJ, DonnellyP: A new statistical method for haplotype reconstruction from population data.Am. J. Hum.Genet.68, 978–989 (2001).
  • Stephens M , SheetP: Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation.Am. J. Hum. Genet.76, 449–462 (2005).
  • Excoffier LG , SchneiderS: Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evolutionary Bioinformatics Online (accepted) (2005).
  • Lee YH , KimHJ, RhoYH, ChoiSJ, JiJD, SongGG: Interleukin-1 receptor antagonist gene polymorphism and rheumatoid arthritis.Rheumatol. Int.24, 133–136 (2004).
  • Cantargel A , NavauxF, Loubet-LescoulièP et al.: Interleukin-1 β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphism. Relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum.42, 1093–1100 (1999).
  • Cvetkovic TJ , Wallberg-JonssonS, Stegmayr B, Rantapala-Dahlqvist S, Lefvert AK: Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-α, IL-1β, IL-1Ra genes. J. Rheumatol.29, 212–219 (2002).
  • Carreira PE , Gonzales-CrespoMR, Ciruelo E et al.: Polymorphism of the inerleukin-1 receptor antagonist gene. A factor in susceptibility to rheumatoid arthritis in Spanish population. Arthritis Rheum.52, 3015–3019 (2005).
  • Gabay C , SmithMF, EidlenD, ArendWP: Interleukin 1 receptor antagonist (IL-1Ra) is an acute phase protein.J. Clin. Invest.199, 2930–2940 (1997).
  • Vamvakopoulos J , GreenC, MetcalfeS: Genetic control of IL-1β bioactivity through differential regulation of the IL-1 receptor antagonist.Eur. J. Immunol.32, 2988–2996 (2002).
  • Santilla S , SavinainenK, HurmeM: Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro.Scand. J. Immunol.47, 195–198 (1998).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.